{"id":"W4225388109","doi":"10.2147/jaa.s355391","title":"Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNP","year":2022,"lang":"en","type":"article","venue":"Journal of Asthma and Allergy","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Thomas Hospital","funders":"Covis Pharma; Regeneron Pharmaceuticals; Sanofi; AstraZeneca; Amgen; Pfizer; Mylan; GlaxoSmithKline","keywords":"Medicine; Dupilumab; Nasal polyps; Clinical endpoint; Placebo; Chronic rhinosinusitis; Confidence interval; Odds ratio; Post-hoc analysis; Internal medicine; Gastroenterology; Sinus (botany); Nasal congestion; Nasal administration; Randomized controlled trial; Nose; Surgery; Pathology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001858487,0.0003997891,0.0009606549,0.000148544,0.0002304999,0.0003948594,0.0001922059,0.0002591765,0.0009694757],"category_scores_gemma":[0.001889418,0.0001263433,0.0006912885,0.0001966966,0.0002448019,0.0003921057,0.0002735857,0.0006140782,0.0001453875],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003383458,"about_ca_system_score_gemma":0.0004551501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007758382,"about_ca_topic_score_gemma":0.003279443,"domain_scores_codex":[0.9991558,0.0003645656,0.00008068907,0.0001417464,0.0001586371,0.00009866942],"domain_scores_gemma":[0.99907,0.0002592888,0.0003679747,0.00005048006,0.00008722596,0.0001650461],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0649282,0.002172848,0.5879403,0.001495974,0.002026503,0.0005889512,0.0004397755,0.001216614,0.03819365,0.0001156168,0.002470169,0.2984113],"study_design_scores_gemma":[0.002686252,0.03280795,0.9558127,0.00008188341,0.000688074,0.001354611,0.0002476273,0.001323315,0.002396195,0.00007979885,0.002497204,0.00002457728],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958287,0.003000995,0.0001418541,0.0001337919,0.00002231639,0.00006444826,0.0001540752,0.00001539973,0.0006383944],"genre_scores_gemma":[0.9990194,0.0003670081,0.0002282396,0.0001001952,0.00002381873,0.0000201178,0.0001378445,0.000001453452,0.0001019824],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001858487,"threshold_uncertainty_score":0.009828746,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003371542923866057,"score_gpt":0.1947153225204501,"score_spread":0.191343779596584,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}